Key result
Transoesophageal echocardiography remains a key imaging modality for diagnosing and managing valvular disease, particularly with the introduction of 3D techniques.
Transoesophageal echocardiography, particularly with the integration of 3D techniques, remains a cornerstone imaging modality for the diagnosis, grading, and interventional monitoring of valvular heart disease.
Answers are grounded in this paper and cite their sources.
Reinforces TEE role in valvular workflows; leaves open need for prospective outcome trials before broader adoption.
Despite significant advancements in the field of cardiovascular imaging, transoesophageal echocardiography remains the key imaging modality in the management of valvular pathologies. This paper provides echocardiographers with an overview of the modern role of TOE in the diagnosis and management of valvular disease. We describe how the introduction of 3D techniques has changed the detection and grading of valvular pathologies and concentrate on its role as a monitoring tool in interventional cardiology. In addition, we focus on the echocardiographic and Doppler techniques used in the assessment of prosthetic valves and provide guidance for the evaluation of prosthetic valves. Finally, we summarise quantitative methods used for the assessment of valvular stenosis and regurgitation and highlight the key areas where echocardiography remains superior over other novel imaging modalities.
No takes yet. Share an insight, caveat, or question.
Wamil et al. (2017) conducted a review in Valvular pathologies. Transoesophageal echocardiography (TOE) was evaluated. Transoesophageal echocardiography remains a key imaging modality for diagnosing and managing valvular disease, particularly with the introduction of 3D techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: